Cargando…

Novel RET agonist for the treatment of experimental neuropathies

The glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) alleviate symptoms of experimental neuropathy, protect and stimulate regeneration of sensory neurons in animal models of neuropathic pain, and restore their functional activity. However, clinical development of GFL proteins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viisanen, Hanna, Nuotio, Ulpukka, Kambur, Oleg, Mahato, Arun Kumar, Jokinen, Viljami, Lilius, Tuomas, Li, Wei, Santos, Hélder A, Karelson, Mati, Rauhala, Pekka, Kalso, Eija, Sidorova, Yulia A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440726/ https://www.ncbi.nlm.nih.gov/pubmed/32811276 http://dx.doi.org/10.1177/1744806920950866

Ejemplares similares

A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat
por: Sidorova, Yulia A., et al.
Publicado: (2017)

The effects of chronic high-dose morphine on microgliosis and the microglial transcriptome in rat spinal cord
por: Ahlström, Fredrik HG, et al.
Publicado: (2023)

Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats
por: Renko, Juho-Matti, et al.
Publicado: (2021)

Small-Molecule Ligands as Potential GDNF Family Receptor Agonists
por: Ivanova, Larisa, et al.
Publicado: (2018)

Spared Nerve Injury Causes Sexually Dimorphic Mechanical Allodynia and Differential Gene Expression in Spinal Cords and Dorsal Root Ganglia in Rats
por: Ahlström, F.H.G., et al.
Publicado: (2021)

RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer
por: Mahato, Arun Kumar, et al.
Publicado: (2020)

Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat
por: Lilius, T O, et al.
Publicado: (2015)

Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson’s disease
por: Mahato, Arun Kumar, et al.
Publicado: (2020)

Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonist with Disease-Modifying Potential for the Treatment of Neurodegeneration
por: Haider, Malik Salman, et al.
Publicado: (2022)

PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential
por: Yadav, Leena, et al.
Publicado: (2020)

Molecular Dynamics Simulations of the Interactions between Glial Cell Line-Derived Neurotrophic Factor Family Receptor GFRα1 and Small-Molecule Ligands
por: Ivanova, Larisa, et al.
Publicado: (2018)

Glial Cell Line–Derived Neurotrophic Factor Receptor Rearranged During Transfection Agonist Supports Dopamine Neurons In Vitro and Enhances Dopamine Release In Vivo
por: Mahato, Arun Kumar, et al.
Publicado: (2019)

Genetic variation in P2RX7 and pain tolerance
por: Kambur, Oleg, et al.
Publicado: (2018)

Disposable Nafion-Coated Single-Walled Carbon Nanotube Test Strip for Electrochemical Quantitative Determination of Acetaminophen in a Finger-Prick Whole Blood Sample
por: Wester, Niklas, et al.
Publicado: (2020)

Simultaneous Detection of Morphine and Codeine in the Presence of Ascorbic Acid and Uric Acid and in Human Plasma at Nafion Single-Walled Carbon Nanotube Thin-Film Electrode
por: Wester, Niklas, et al.
Publicado: (2019)

Electrochemical Detection of Morphine in Untreated Human Capillary Whole Blood
por: Verrinder, Elsi, et al.
Publicado: (2021)

Zebrafish GDNF and its co-receptor GFRα1 activate the human RET receptor and promote the survival of dopaminergic neurons in vitro
por: Saarenpää, Tuulia, et al.
Publicado: (2017)

Electrochemical Detection of Oxycodone and Its Main Metabolites with Nafion-Coated Single-Walled Carbon Nanotube Electrodes
por: Mynttinen, Elsi, et al.
Publicado: (2020)

The Impact of Software Used and the Type of Target Protein on Molecular Docking Accuracy
por: Ivanova, Larisa, et al.
Publicado: (2022)

Structural and functional interactions between six-transmembrane μ-opioid receptors and β(2)-adrenoreceptors modulate opioid signaling
por: Samoshkin, Alexander, et al.
Publicado: (2015)

Identification of Natural Compounds against Neurodegenerative Diseases Using In Silico Techniques
por: Ivanova, Larisa, et al.
Publicado: (2018)

Multitarget Approach to Drug Candidates against Alzheimer’s Disease Related to AChE, SERT, BACE1 and GSK3β Protein Targets
por: Ivanova, Larisa, et al.
Publicado: (2020)

Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors
por: Selberg, Simona, et al.
Publicado: (2021)

Worse health‐related quality of life, impaired functioning and psychiatric comorbidities are associated with excess mortality in patients with severe chronic pain
por: Vartiainen, Pekka, et al.
Publicado: (2022)

Precision therapy for RET-altered cancers with RET inhibitors
por: Thein, Kyaw Z., et al.
Publicado: (2021)

RET kinase inhibitors for RET-altered thyroid cancers
por: Vodopivec, Danica M., et al.
Publicado: (2022)

RET signaling pathway and RET inhibitors in human cancer
por: Regua, Angelina T., et al.
Publicado: (2022)

Etiology of Minor Troponin Elevations in Patients with Atrial Fibrillation at Emergency Department–Tropo-AF Study
por: Jaakkola, Samuli, et al.
Publicado: (2019)

Pain interference type and level guide the assessment process in chronic pain: Categorizing pain patients entering tertiary pain treatment with the Brief Pain Inventory
por: Miettinen, Teemu, et al.
Publicado: (2019)

Machine Learning and Pathway Analysis-Based Discovery of Metabolomic Markers Relating to Chronic Pain Phenotypes
por: Miettinen, Teemu, et al.
Publicado: (2022)

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
por: Solomon, Benjamin J., et al.
Publicado: (2020)

Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization
por: Schmutzler, Brian S, et al.
Publicado: (2011)

Selective RET kinase inhibition for patients with RET-altered cancers
por: Subbiah, V, et al.
Publicado: (2018)

Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers
por: Adashek, Jacob J., et al.
Publicado: (2021)

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
por: Rosen, Ezra Y., et al.
Publicado: (2022)

Precision oncology with selective RET inhibitor selpercatinib in RET-rearranged cancers
por: Gouda, Mohamed A., et al.
Publicado: (2023)

RET/GFRα Signals Are Dispensable for Thymic T Cell Development In Vivo
por: Almeida, Afonso Rocha Martins, et al.
Publicado: (2012)

Health‐related quality of life in patients with chronic orofacial pain compared with other chronic pain patients
por: Tanner, Johanna, et al.
Publicado: (2022)

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
por: Santoro, M., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_a2rabt9c3b8uq915hmhip5ljkr